# NIH Funds Linshom Respiratory Monitoring

On November 5, 2026, Linshom Medical received a **$3.5 million NIH/NHLBI SBIR Phase 2B grant** to develop wireless, portable continuous respiratory monitoring and conduct a multi-center clinical trial. The trial will evaluate the medical-economic benefits of earlier detection and intervention. This is a funded project, not an open solicitation; it signals federal investment in patient-monitoring technology and may create collaboration opportunities in device engineering and clinical-trial work.

- The award supports both technology development and clinical evidence generation, linking device performance with the value of earlier intervention.
- Medical-device contractors, engineering firms, and clinical research organizations may evaluate whether their capabilities align with Linshom Medical’s funded development and trial activities.
- The project’s stated focus on medical-economic benefits may be relevant to organizations developing or evaluating respiratory monitoring technologies for healthcare settings.

**Jurisdictions:** federal
**Industries:** Healthcare
**Topics:** Grants & Funding
**Published:** November 05, 2026

### Government Entities
- National Institutes of Health (NIH)
- National Heart, Lung, and Blood Institute (NHLBI)

### Vendors
- Linshom Medical, Inc. (SBIR grant awardee)

### Key Quotes
> A previous study at Ohio State Wexner Medical Center (OSU) proved the early detection capability of the Linshom Medical sensor, providing health care providers time to intervene before a crisis develops. Now, with the new clinical trial, we aim to quantify the medical-economic benefits of early detection and early intervention
> — Richard Hughen, Chief Executive Officer

### Sources
- [Linshom Medical awarded a $3.5M SBIR grant - The Bergen Record](https://www.northjersey.com/press-release/story/262579/linshom-medical-awarded-a-3-5m-sbir-grant) - Bergen Record